| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-8703(96)90313-0 |
| P698 | PubMed publication ID | 8831368 |
| P50 | author | Pascal de Groote | Q56947582 |
| P2093 | author name string | F Puisieux | |
| P Y Hatron | |||
| J Y Cesbron | |||
| A Millaire | |||
| G Ducloux | |||
| B Jude | |||
| O Bouillanne | |||
| P2860 | cites work | Lung cancer, immune thrombocytopenia and the lupus inhibitor | Q33447236 |
| Lupus anticoagulant: a clinical and laboratory study of 100 cases | Q33447286 | ||
| Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus | Q33448275 | ||
| Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus | Q41837002 | ||
| Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies | Q44728484 | ||
| Valvular heart disease in the primary antiphospholipid syndrome | Q46730841 | ||
| A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. | Q51059360 | ||
| A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS | Q56417998 | ||
| Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies | Q67511161 | ||
| Cardiac involvement in patients with primary antiphospholipid syndrome | Q67977013 | ||
| Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population | Q68035493 | ||
| Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population | Q68343284 | ||
| Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events | Q69874910 | ||
| Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody | Q69946465 | ||
| Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases | Q69952447 | ||
| The management of thrombosis in the antiphospholipid-antibody syndrome | Q72619159 | ||
| Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients | Q72764443 | ||
| Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant | Q33381987 | ||
| Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus | Q33393531 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart valve disease | Q1130519 |
| P304 | page(s) | 790-795 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a case-control study | |
| P478 | volume | 132 |
| Q42209290 | Antiphosphatidyl serine autoantibodies and premature coronary events. |
| Q74456594 | Hughes (antiphospholipid) syndrome. Clinical features |
| Q61943926 | LUPUS ANTICOAGULANTS AND ANTIPHOSPHOLIPID ANTIBODIES |
| Q74521081 | [Pathology of diseases of extracardiac origin. VI. Disease of the connective tissue and heart] |
Search more.